Robert E. Landry - 03 Feb 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Reporting relationship: EVP Finance CFO
Issuer ticker: REGN
Reported as of: 03 Feb 2023
Net transaction value: -$1,753,048
SEC form: 4
Accepted by SEC: 07 Feb 2023, 15:09:21 UTC
Prior SEC filing: 20 Dec 2022
Next SEC filing: 29 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/**Robert E. Landry

Key filing fact

Robert E. Landry filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 07 Feb 2023.

Key facts

This page summarizes Robert E. Landry's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
18 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Feb 2023, 15:09.

Change

Previous filing in this sequence was filed on 20 Dec 2022.
Current net transaction value: -$1,753,048.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Sale

Transaction value: $564,966
Shares: -739
Change %: -2.3%
Price: $764.50
Shares after: 32,105
Date: 03 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Options Exercise

Transaction value: $1,145,760
Shares: +3,000
Change %: +9.3%
Price: $381.92
Shares after: 35,105
Date: 03 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Tax liability

Transaction value: $1,740,604
Shares: -2,248
Change %: -6.4%
Price: $774.29
Shares after: 32,857
Date: 03 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $39,936
Shares: -51
Change %: -0.16%
Price: $783.05
Shares after: 32,806
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $88,623
Shares: -113
Change %: -0.34%
Price: $784.27
Shares after: 32,693
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F2

REGN transaction

Common Stock

Sale

Transaction value: $61,299
Shares: -78
Change %: -0.24%
Price: $785.88
Shares after: 32,615
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F3

REGN transaction

Common Stock

Sale

Transaction value: $66,848
Shares: -85
Change %: -0.26%
Price: $786.45
Shares after: 32,530
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F4

REGN transaction

Common Stock

Sale

Transaction value: $45,673
Shares: -58
Change %: -0.18%
Price: $787.47
Shares after: 32,472
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $78,073
Shares: -99
Change %: -0.3%
Price: $788.62
Shares after: 32,373
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F5

REGN transaction

Common Stock

Sale

Transaction value: $38,663
Shares: -49
Change %: -0.15%
Price: $789.05
Shares after: 32,324
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $7,904
Shares: -10
Change %: -0.03%
Price: $790.41
Shares after: 32,314
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $2,373
Shares: -3
Change %: -0.01%
Price: $791.00
Shares after: 32,311
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $1,587
Shares: -2
Change %: -0.01%
Price: $793.33
Shares after: 32,309
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN transaction

Common Stock

Sale

Transaction value: $78,666
Shares: -99
Change %: -0.31%
Price: $794.61
Shares after: 32,210
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F6

REGN transaction

Common Stock

Sale

Transaction value: $46,929
Shares: -59
Change %: -0.18%
Price: $795.41
Shares after: 32,151
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F7

REGN transaction

Common Stock

Sale

Transaction value: $14,336
Shares: -18
Change %: -0.06%
Price: $796.43
Shares after: 32,133
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1, F8

REGN transaction

Common Stock

Sale

Transaction value: $22,328
Shares: -28
Change %: -0.09%
Price: $797.43
Shares after: 32,105
Date: 06 Feb 2023
Ownership: Direct
Footnotes: F1

REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 250
Date: 03 Feb 2023
Ownership: By 401(k) Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -3,000
Change %: -79%
Price: $0.000000
Shares after: 800
Date: 03 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000
Exercise price: $381.92
Footnotes: F1, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Footnote F2

Represents volume-weighted average price of sales of 113 shares of Company stock on February 6, 2023 at prices ranging from $784.02 to $784.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F3

Represents volume-weighted average price of sales of 78 shares of Company stock on February 6, 2023 at prices ranging from $785.85 to $785.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F4

Represents volume-weighted average price of sales of 85 shares of Company stock on February 6, 2023 at prices ranging from $786.03 to $786.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F5

Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $788.48 to $788.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F6

Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $794.28 to $794.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F7

Represents volume-weighted average price of sales of 59 shares of Company stock on February 6, 2023 at prices ranging from $795.26 to $795.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F8

Represents volume-weighted average price of sales of 18 shares of Company stock on February 6, 2023 at prices ranging from $796.35 to $796.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

Footnote F9

The stock option award vests in four equal annual installments, commencing one year after the date of grant.